Literature DB >> 16572119

Renal pathology in idiopathic membranous nephropathy: a new perspective.

S Troyanov1, L Roasio, M Pandes, A M Herzenberg, D C Cattran.   

Abstract

Histology findings in idiopathic membranous nephropathy (MGN) have been associated with the risk of renal failure, but whether they are independent of the clinical variables at the time of biopsy, predict rate of progression, or should guide therapy is uncertain. Renal biopsies of 389 adult MGN patients were evaluated semiquantitatively for interstitial fibrosis, tubular atrophy, vascular sclerosis, focal and segmental glomerulosclerosis lesions (FSGS), complement deposition, and stage and synchrony of deposits by electron microscopy (EM). Associations were tested between these findings and the rate of renal function decline (slope), renal survival, remission in proteinuria, and response to immunosuppression. Patients with a greater degree of tubulo-interstitial disease, vascular sclerosis, and secondary FSGS were older, had a higher mean arterial pressure, and a lower creatinine clearance at presentation. Although these histologic features were associated with a reduced renal survival, they did not predict this outcome independently of the baseline clinical variables nor did they correlate with the rate of decline in function or with baseline proteinuria. Furthermore, the severity of tubulo-interstitial and vascular lesions did not preclude a remission in proteinuria in those who received immunosuppressive therapy. Neither stage nor synchronicity of EM deposits nor the amount of complement deposition predicted renal survival but the latter did correlate with progression rate. In MGN, certain histologic changes are associated with renal survival outcome. However, the indicators of chronic injury are associated with age, blood pressure, and creatinine clearance at presentation and not with rate of disease progression or initial proteinuria.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16572119     DOI: 10.1038/sj.ki.5000289

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  30 in total

1.  Prognostic value of risk score and urinary markers in idiopathic membranous nephropathy.

Authors:  Jan A J G van den Brand; Julia M Hofstra; Jack F M Wetzels
Journal:  Clin J Am Soc Nephrol       Date:  2012-05-17       Impact factor: 8.237

2.  Relapse or worsening of nephrotic syndrome in idiopathic membranous nephropathy can occur even though the glomerular immune deposits have been eradicated.

Authors:  Chadwick E Barnes; William A Wilmer; Raul A Hernandez; Christopher Valentine; Leena S Hiremath; Tibor Nadasdy; Anjali A Satoskar; Rose L Shim; Brad H Rovin; Lee A Hebert
Journal:  Nephron Clin Pract       Date:  2011-07-08

3.  Can genetics risk-stratify patients with membranous nephropathy?

Authors:  Andrew S Bomback; Ali G Gharavi
Journal:  J Am Soc Nephrol       Date:  2013-07-05       Impact factor: 10.121

4.  Urine podocyte mRNAs, proteinuria, and progression in human glomerular diseases.

Authors:  Larysa Wickman; Farsad Afshinnia; Su Q Wang; Yan Yang; Fei Wang; Mahboob Chowdhury; Delia Graham; Jennifer Hawkins; Ryuzoh Nishizono; Marie Tanzer; Jocelyn Wiggins; Guillermo A Escobar; Bradley Rovin; Peter Song; Debbie Gipson; David Kershaw; Roger C Wiggins
Journal:  J Am Soc Nephrol       Date:  2013-09-19       Impact factor: 10.121

5.  The natural history of the non-nephrotic membranous nephropathy patient.

Authors:  Michelle A Hladunewich; Stephan Troyanov; Jennifer Calafati; Daniel C Cattran
Journal:  Clin J Am Soc Nephrol       Date:  2009-08-06       Impact factor: 8.237

6.  Kidney Biopsy Is Required for Nephrotic Syndrome with PLA2R+ and Normal Kidney Function: The Con View.

Authors:  Shane A Bobart; Fernando C Fervenza
Journal:  Kidney360       Date:  2020-07-13

7.  Noninvasive Diagnosis of PLA2R-Associated Membranous Nephropathy: A Validation Study.

Authors:  Shane A Bobart; Heedeok Han; Shahrzad Tehranian; An S De Vriese; Juan Carlos Leon Roman; Sanjeev Sethi; Ladan Zand; Cristina Andrades Gomez; Callen D Giesen; Maria Jose Soler; Andrew S Bomback; Fernando C Fervenza
Journal:  Clin J Am Soc Nephrol       Date:  2021-11-15       Impact factor: 8.237

8.  Pathological predictors of renal outcomes in nephrotic idiopathic membranous nephropathy with decreased renal function.

Authors:  Yizhi Chen; Li Tang; Zhe Feng; Xueying Cao; Xuefeng Sun; Moyan Liu; Shuwen Liu; Xueguang Zhang; Ping Li; Ribao Wei; Qiang Qiu; Guangyan Cai; Xiangmei Chen
Journal:  J Nephrol       Date:  2014-02-13       Impact factor: 3.902

9.  Low- and high-molecular-weight urinary proteins as predictors of response to rituximab in patients with membranous nephropathy: a prospective study.

Authors:  Maria V Irazabal; Alfonso Eirin; John Lieske; Laurence H Beck; Sanjeev Sethi; Timothy M Borland; John J Dillon; Patrick H Nachman; Samih H Nasr; Lynn D Cornell; Nelson Leung; Daniel C Cattran; Fernando C Fervenza
Journal:  Nephrol Dial Transplant       Date:  2012-09-17       Impact factor: 5.992

10.  Glomerulosclerosis predicts poor renal outcome in patients with idiopathic membranous nephropathy.

Authors:  Cuimei Wei; Yongcheng He; Tong Li; Haofei Hu; Haiying Song; Dongli Qi; Yuan Cheng; Jia Chen; Mijie Guan; Xiaohua Xiao; Junyi Li
Journal:  Int Urol Nephrol       Date:  2020-09-22       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.